← Back to Search

Brief Parent-Teen Dating Violence Prevention Program for Adolescent Violence (ETHR Trial)

N/A
Recruiting
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through completion of completing 3 month post-intervention survey, an average of 12 months
Awards & highlights

ETHR Trial Summary

This trial studies if a brief parent-teen dating violence prevention program is feasible & acceptable in pediatric primary care. 4 healthcare providers will deliver it & compare it to routine well-child care.

Who is the study for?
This trial is for English-speaking pediatricians, nurse practitioners, or physician assistants and their patients aged 11 to 15 who have an upcoming well-child visit. It also includes the caregivers of these adolescents if they are attending the visit and speak English.Check my eligibility
What is being tested?
The study tests a brief intervention called Engaging Together for Healthy Relationships (ETHR) aimed at preventing dating violence among adolescents. ETHR will be delivered during routine pediatric care visits and compared with standard well-child care.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there are no direct physical side effects expected from participating in this study.

ETHR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through completion of completing 3 month post-intervention survey, an average of 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through completion of completing 3 month post-intervention survey, an average of 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of participants who are consented out of the total who are eligible
Percentage of participants who are eligible out of the total who are approached
Percentage of participants who complete the 1-month post-intervention survey out of the total who consented
+5 more
Secondary outcome measures
Attitudes about ARA, change in outcome between baseline and 3 months
Parent-adolescent communication around dating and ARA, change in outcome over time
Parental monitoring around dating and ARA, change in outcome over time
+3 more

ETHR Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention (Engaging Together for Healthy Relationships)Experimental Treatment1 Intervention
Providers and families in the intervention arm will receive the ETHR program which includes a clinician training, provider scripts, resource guides, a comprehensive website, and warm referral processes.
Group II: Control (Receipt of regular well-child care)Active Control1 Intervention
Providers and families in the control arm will receive regular well-child care. All providers in the control arm will have access to ETHR after the pilot trial is over

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,723 Previous Clinical Trials
16,342,988 Total Patients Enrolled

Media Library

Engaging Together for Healthy Relationships Clinical Trial Eligibility Overview. Trial Name: NCT05880979 — N/A
Domestic Violence Research Study Groups: Intervention (Engaging Together for Healthy Relationships), Control (Receipt of regular well-child care)
Domestic Violence Clinical Trial 2023: Engaging Together for Healthy Relationships Highlights & Side Effects. Trial Name: NCT05880979 — N/A
Engaging Together for Healthy Relationships 2023 Treatment Timeline for Medical Study. Trial Name: NCT05880979 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in this experiment still open to qualified participants?

"As per clinicaltrials.gov, this medical trial is currently not recruiting patients; however, the study was first published on June 1st 2023 and edited most recently in May 26th of the same year. Though participation isn't available at present there are 29 other studies actively looking for candidates."

Answered by AI

What are the anticipated outcomes of this research?

"The primary focus of this observation period, which is expected to be 6 months in length, is to determine the proportion of eligible participants who consent. Secondary objectives include analyzing how many patients take advantage of ARA resources at each stage, investigating any change in attitude towards abusive relationships with a 1-5 scale (1=not abusive, 5=very abusive), and evaluating parent-adolescent communication on dating and ARA with yes/no answer choices (yes=has communicated, no=has not communicated)."

Answered by AI
~0 spots leftby May 2024